Sudeep Pharma Limited (NSE:SUDEEPPHRM)

India · Delayed Price · Currency is INR

842.95

-9.55 (-1.12%)

Jun 19, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2004	FY 2003
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003
Pharmaceutical, Food and Nutrition	3.63B	3.30B	3.11B	3.30B	2.87B
Pharmaceutical, Food and Nutrition Growth	9.73%	6.39%	-5.90%	14.89%	-
Specialty Ingredients	2.80B	1.72B	1.49B	985.88M	572.51M
Specialty Ingredients Growth	63.04%	15.40%	50.75%	72.20%	-
Total	6.42B	5.02B	4.59B	4.29B	3.45B
Total Growth	27.94%	9.30%	7.12%	24.41%	4999.06%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2004	FY 2003
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003
Asia-Pacific	-	-	734.16M	537.90M
Asia-Pacific Growth	-	-	36.49%	-
Europe	-	-	663.85M	516.72M
Europe Growth	-	-	28.47%	-
India	2.04B	1.63B	1.35B	1.16B
India Growth	25.14%	20.77%	16.78%	1614.13%
Middle East and Africa	-	-	237.15M	240.53M
Middle East and Africa Growth	-	-	-1.41%	-
Others	2.02B	1.93B	238.50M	139.65M
Others Growth	4.96%	708.35%	70.78%	-
United States of America	951.81M	1.03B	1.06B	852.88M
United States of America Growth	-7.68%	-2.82%	24.39%	-
Total	5.02B	4.59B	4.29B	3.45B
Total Growth	9.30%	7.12%	24.41%	4999.05%